Considering our findings on the antitumor effects of HSP70/IL-2-treated NK cells in our in vivo rat model of induced GBM, we envision translation of this novel treatment approach to tackle GBM in humans, although there are some ambiguities which remain. Here, IL2 is linked to glioblastoma.